HIV Infections: all 4,340 studies

Page 5 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• Storytelling to Increase Family Support for Pre Exposure Prophylaxis UseCompletedNCT04071470Not applicableResults posted
• A Couples-based Intervention for Transgender Women and Their PartnersTerminatedNCT04067661Not applicableResults posted
• Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINKCompletedNCT04064567Not applicableResults posted
• HIV Oral Testing Infographic ExperimentCompletedNCT04061915Not applicableResults posted
• Acute Neural and Immune Effects of Alcohol in People Living With HIV InfectionCompletedNCT04050735Not applicableResults posted
• Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate)CompletedNCT04048382Not applicableResults posted
• Safety and Pharmacokinetic Study of Tenofovir Alafenamide (TAF)/Elvitegravir (EVG) Administered RectallyCompletedNCT04047420Phase 1Results posted
• The PrEP (Pre-exposure Prophylaxis) SMART StudyCompletedNCT04038060Not applicableResults posted
• Mobile Enhanced Prevention Support for People Leaving JailCompletedNCT04036396Not applicableResults posted
• Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)CompletedNCT04021290Phase 3Results posted
• 'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase InhibitorCompletedNCT04019873Results posted
• Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)CompletedNCT04001803Phase 3Results posted
• Web-Based Cognitive Behavioral Stress Management for Latino Sexual Minority Men Living With HIV and CancerCompletedNCT03993054Not applicableResults posted
• Biomedical HIV/AIDS Prevention Program YunnanTerminatedNCT03992274Not applicableResults posted
• Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled TrialCompletedNCT03991013Phase 2Results posted
• Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese DescentCompletedNCT03984838Phase 1Results posted
• Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral ContraceptiveCompletedNCT03984825Phase 1Results posted
• Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) StudyTerminatedNCT03984812Phase 1Results posted
• Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis RegimensCompletedNCT03976752Phase 1Results posted
• Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyCompletedNCT03965923Phase 3Results posted
• Scaling up an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam: an Implementation TrialCompletedNCT03952520Not applicableResults posted
• Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected AdultsCompletedNCT03945981Phase 3Results posted
• Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)CompletedNCT03934931Not applicableResults posted
• Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult ParticipantsCompletedNCT03934541Phase 1Results posted
• Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)CompletedNCT03934437Not applicableResults posted
• Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult ParticipantsCompletedNCT03928821Phase 1Results posted
• A Text-Based Adherence Game for Young People Living With HIV in GhanaCompletedNCT03928717Not applicableResults posted
• Mobile Technology to Extend Clinic-based Counseling for HIV+s in UgandaCompletedNCT03928418Not applicableResults posted
• Dolutegravir Pediatric Liquid Formulation StudyCompletedNCT03921723Phase 1Results posted
• Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)CompletedNCT03921424Phase 3Results posted
• Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI TractCompletedNCT03917420Phase 1Results posted
• Plan and Pledge, HIV Self-testing in South AfricaCompletedNCT03898557Not applicableResults posted
• 90 DAYS: An Entertainment Education Intervention to Evaluate a Short Film About HIV Status DisclosureCompletedNCT03898063Not applicableResults posted
• Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender WomenCompletedNCT03897049Not applicableResults posted
• Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy VolunteersCompletedNCT03894124Phase 1Results posted
• Doravirine, Rifapentine and Isoniazid InteractionCompletedNCT03886701Phase 1Results posted
• Standardized Patient Encounters to Improve PrEP Counseling for Adolescent Girls and Young Women in KenyaCompletedNCT03875950Not applicableResults posted
• Reducing Post-Hospital Mortality in HIV-infected Adults in TanzaniaCompletedNCT03858998Not applicableResults posted
• A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected CellsCompletedNCT03856996Phase 1Results posted
• Telemedicine for PrEP Throughout MississippiCompletedNCT03840382Not applicableResults posted
• Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/EmtricitabineCompletedNCT03836729Phase 1Results posted
• CareConekta: A Smartphone App to Improve Engagement in HIV CareCompletedNCT03836625Not applicableResults posted
• Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral TherapyCompletedNCT03820323Not applicableResults posted
• Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG)CompletedNCT03816696Phase 1Results posted
• Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)CompletedNCT03803683Not applicableResults posted
• Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cARTTerminatedNCT03787095Phase 1/2Results posted
• A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive AdultsCompletedNCT03784079Phase 2Results posted
• Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy AdultsCompletedNCT03783130Phase 1Results posted
• HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)CompletedNCT03763942Not applicableResults posted
• The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of AgeCompletedNCT03760458Phase 1/2Results posted
• PlusCare: Mobile Platform to Increase Linkage to Care in Adolescents Living With HIV/AIDSCompletedNCT03758066Not applicableResults posted
• Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in GermanyCompletedNCT03754803Results posted
• Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDSCompletedNCT03746600Not applicableResults posted
• Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1CompletedNCT03739996Phase 2Results posted
• Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult ParticipantsCompletedNCT03735849Phase 1Results posted
• Expanding HIV Testing Among Uganda Adults Who Utilize Traditional HealersCompletedNCT03718871Not applicableResults posted
• Dual bNAb Treatment in ChildrenCompletedNCT03707977Phase 1/2Results posted
• Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected AdolescentsCompletedNCT03682848Phase 3Results posted
• Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care SettingsCompletedNCT03681912Results posted
• Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing TenofovirCompletedNCT03670355Phase 1Results posted
• VITAL Start: Brief Facility-based Video InterventionCompletedNCT03654898Not applicableResults posted
• eTest: Real-time, Remote Monitoring System for Home-based HIV Testing Among High-risk Men Who Have Sex With MenCompletedNCT03654690Not applicableResults posted
• Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE StudyCompletedNCT03639311Phase 2Results posted
• Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV InfectionCompletedNCT03637660Phase 4Results posted
• The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifECompletedNCT03635788Phase 3Results posted
• Alcohol Monitor ValidationCompletedNCT03617705Not applicableResults posted
• A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)CompletedNCT03615183Phase 1Results posted
• A Stigma Reduction Intervention at Time of Entry Into Antenatal Care to Improve PMTCT Services in TanzaniaCompletedNCT03600142Not applicableResults posted
• Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female PopulationCompletedNCT03593655Phase 2Results posted
• Interventions to Improve the HIV PrEP Cascade Among Methamphetamine UsersCompletedNCT03584282Not applicableResults posted
• Young Men's Health Project Targeting HIV Risk Reduction and Substance AbuseCompletedNCT03577301Not applicableResults posted
• A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254CompletedNCT03575962Phase 1Results posted
• Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living With HIVCompletedNCT03575143Results posted
• Pre-exposure Prophylaxis (PrEP) at HomeCompletedNCT03569813Not applicableResults posted
• The Role of Probiotics in HIV Patients With Immunological Non-ResponderCompletedNCT03568812Phase 2Results posted
• HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine StudyCompletedNCT03560258Phase 1/2Results posted
• We Prevent: A Dyadic Approach to HIV Prevention and Care Among Young Male CouplesCompletedNCT03551938Not applicableResults posted
• PrEP Communication Intervention for Female Clients of a Needle ExchangeCompletedNCT03541642Not applicableResults posted
• Adherence Interventions for HIV Youth Via Text & Cell Phone - Sequential Multiple Assignment Randomized Trial (SMART)CompletedNCT03535337Not applicableResults posted
• Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South AfricaCompletedNCT03529409Not applicableResults posted
• Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1CompletedNCT03518060Results posted
• Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)CompletedNCT03512418Phase 3Results posted
• Tambua Mapema Plus - to Discover HIV Infection Early and Prevent Onward TransmissionCompletedNCT03508908Not applicableResults posted
• Effect of Evolocumab on Coronary Endothelial FunctionCompletedNCT03500302Phase 2Results posted
• VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2CompletedNCT03499795Phase 2Results posted
• More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and AdolescentsCompletedNCT03497676Phase 1/2Results posted
• 2-5 Intermittent Caloric Restriction in HIVTerminatedNCT03489109Not applicableResults posted
• Retention in HIV Care for Hispanic ImmigrantsCompletedNCT03484117Not applicableResults posted
• Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)CompletedNCT03446573Phase 3Results posted
• To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy VolunteersCompletedNCT03441984Phase 1Results posted
• A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese MenCompletedNCT03422172Phase 1Results posted
• Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)CompletedNCT03414372Not applicableResults posted
• Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected AdultsCompletedNCT03409276Phase 1Results posted
• Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03408899Phase 1Results posted
• Clinical Trial of HIV Vaccine Combinations in Healthy Men and WomenCompletedNCT03408262Phase 1Results posted
• The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in NigeriaCompletedNCT03394391Not applicableResults posted
• Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected AdultsCompletedNCT03387150Phase 1Results posted
• Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and PostpartumCompletedNCT03386578Phase 2Results posted
• Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase InhibitorsCompletedNCT03382834Phase 2Results posted
• Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United StatesCompletedNCT03382418Phase 1Results posted

← HIV Infections overview